ea0029p718 | Diabetes | ICEECE2012
Esteves C.
, Neves M.
, Belo S.
, Pereira M.
, Sousa Z.
, Carvalho D.
Introduction: The continuous subcutaneous insulin infusion (CSII) is an alternative to multiple daily injection therapy in type 1 diabetes and its use is increasingly common due to the beneficial effects on the glycemic control of the patient.Aims: To find differences on outcomes of CSII therapy between genders. Patients and methods: Patients on CSII therapy in our department were included in the study and we recorded outcomes regarding the following set...